
Most optional electrical features shown here can be includ-ed on ASCO valves approved by UL, FM, and CSA. Identify the options you want by adding the appropriate pre-fix to the catalog number of the valve you are specifying.
AC (~): rectified coil construction. A valve supplied with the explosionproof operator will be identified with prefix EM or WSEM before the catalogue number. PRODUCT CODE.
ASCO offers the world’s most comprehensive family of prod-ucts that hold approvals from the leading global agencies — UL, CSA, FM, ATEX, and IECEx. In addition, our valves are inspected and certified to NEPSI in China, INMETRO in Brazil, and TR CU in Russia.
ASCO | 艾默生 CN
ASCO 供应的各种流体控制解决方案可以融入数以百计的过程、工业、分析和医疗应用。 我们的产品目录包含了超过 50,000 种精密设计的阀门,可以帮助客户维持运营并推动关键数字化转型,还能为他们的快速交付和优质服务提供所需的支持。
Safety and Efficacy of Endovascular Fiducial Marker Insertion for ...
Purpose: To evaluate the safety and efficacy of endovascular fiducial markers (EVFMs) for CyberKnife stereotactic radiation therapy (RT) of malignant lung neoplasms in patients with …
Safety and Efficacy of Endovascular Fiducial Marker Insertion for ...
2017年8月1日 · The present study demonstrates the feasibility and high technical success of EVFM insertion, enabling CyberKnife stereotactic RT planning in all cases. In addition, despite selection bias toward patients with greater comorbidity in the EVFM group, there were fewer complications with EVFMs than with PTFMs.
These solenoid valves are intended for use on clean dry air or inert gas, filtered to 40 micrometres or better. The dew point of the media should be at least 10°C (18° F) below the minimum …
ASCO Power Technologies | Schneider Electric USA
Improve power resilience with reliable critical power products and services from ASCO Power Technologies, helping companies since 1888.
成均馆大学:使用 ASCO-VF 和 ESMO-MCBS 报销后肿瘤药物临床获 …
2024年3月1日 · 研究者使用美国临床肿瘤学会价值框架(ASCO-VF)和欧洲医学肿瘤学会临床益处大小评估量表(ESMO-MCBS)评估了药物的临床效益得分变化情况,并进行了配对t检验,以检验初步出版物和随后出版物之间得分是否有差异。
Safety and Efficacy of Endovascular Fiducial Marker Insertion for ...
EVFM placement was indicated in patients with contraindications to transthoracic FM placement (ie, coagulopathy, previous pneumonectomy, severe emphysema, severely altered pulmonary function test results, or anatomically difficult access to nodules, such as in …